Join
Live feed
·
PRReleasevia Quantisnow
Codexis Inc. logo

Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics

ByQuantisnow·Wall Street's wire, on your screen.
CDXS· Codexis Inc.
Industrials

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CDXS (Codexis Inc.) and more on Quantisnow.